Follow

Submissions from 2023

Link

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone., Rajiv Agarwal, Bertram Pitt, Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Luis M Ruilope, Csaba P Kovesdy, Katherine Tuttle, Muthiah Vaduganathan, Christoph Wanner, Sameer Bansilal, Martin Gebel, Amer Joseph, Robert Lawatscheck, and George L Bakris

Link

Author Response to "Insulin Dosing Safety in CKD"., Radica Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine Tuttle

Link

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease., Radica Alicic, Joshua J Neumiller, and Katherine Tuttle

Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6, SC Bain, Katherine Tuttle, and See Full List of Authors in Comments

Link

Proteomic changes induced by longevity-promoting interventions in mice., Adam R Burns, Jack Wiedrick, Alicia Feryn, Michal Maes, Mukul K Midha, David H Baxter, Seamus R Morrone, Timothy J Prokop, Charu Kapil, Michael R Hoopmann, Ulrike Kusebauch, Eric W Deutsch, Noa Rappaport, Kengo Watanabe, Robert L Moritz, Richard A Miller, Jodi A Lapidus, and Eric S Orwoll

Link

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence., James L Buxbaum, Martin Freeman, Stuart K Amateau, Jean M Chalhoub, Aneesa Chowdhury, Nayantara Coelho-Prabhu, Rishi Das, Madhav Desai, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly H Ruan, Jonathan Sadik, Sunil G Sheth, Nikhil R Thiruvengadam, Nirav C Thosani, Selena Zhou, and Bashar J Qumseya

Link

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations., James L Buxbaum, Martin Freeman, Stuart K Amateau, Jean M Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly H Ruan, Sunil G Sheth, Nikhil R Thiruvengadam, Nirav C Thosani, and Bashar J Qumseya

Link

Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network., Dhruti P Chen, Margaret E Helmuth, Abigail R Smith, Pietro A Canetta, Isabelle Ayoub, Krzysztof Mucha, Mahmoud Kallash, Jeffrey B Kopp, Rasheed Gbadegesin, Brenda W Gillespie, Larry A Greenbaum, Rulan S Parekh, Tracy E Hunley, C John Sperati, David T Selewski, Jason Kidd, Aftab Chishti, Kimberly Reidy, Amy K Mottl, Debbie S Gipson, Tarak Srivastava, Katherine E Twombley, CureGN Consortium, and Katherine Tuttle

Link

Does Offloading with Felt Foot Plates Heal Diabetic Foot Ulcers?, Deborah Christensen and Albert Botchway

Link

Empagliflozin in Patients with Chronic Kidney Disease., The EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine R Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, Radica Alicic, Ann Cooper, and Lisa Davis

Link

Tirzepatide decreases systolic and diastolic blood pressure., Sidar Copur, Atalay Demiray, David Cherney, Katherine Tuttle, and Mehmet Kanbay

Link

Tirzepatide and potential use for metabolically healthy obesity., Sidar Copur, Cem Tanriover, Furkan Yavuz, Katherine R Tuttle, and Mehmet Kanbay

Link

Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?, Sidar Copur, Abdullah Yildiz, Carlo Basile, Katherine R Tuttle, and Mehmet Kanbay

Link

Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial., Michael I D'Angelica, Ryan J Ellis, Jason B Liu, Brian C Brajcich, Mithat Gönen, Vanessa M Thompson, Mark E Cohen, Susan K Seo, Emily C Zabor, Michele L Babicky, David J Bentrem, Stephen W Behrman, Kimberly A Bertens, Scott A Celinski, Carlos H F Chan, Mary Dillhoff, Matthew E B Dixon, Carlos Fernandez-Del Castillo, Sepideh Gholami, Michael G House, Paul J Karanicolas, Harish Lavu, Shishir K Maithel, John C McAuliffe, Mark J Ott, Bradley N Reames, Dominic E Sanford, Umut Sarpel, Courtney L Scaife, Pablo E Serrano, Travis Smith, Rebecca A Snyder, Mark S Talamonti, Sharon M Weber, Adam C Yopp, Henry A Pitt, and Clifford Y Ko

Needs Assessment: Characterizing resident knowledge gaps in inpatient care of persons with Cystic Fibrosis to inform a quality improvement educational intervention, S Eglin, M Drobny, and AA Lambert

Link

Empagliflozin in Patients with Chronic Kidney Disease., EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, and The EMPA-KIDNEY Collaborative Group

Efficacy, and safety of remdesivir in people with moderately and severely reduced kidney function hospitalized for COVID-19: The REDPINE study, JRS Fernandez, Katherine Tuttle, and See full list of authors in comments

Link

Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle

Link

Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle

Link

National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017., Rodolfo J Galindo, Shealeigh A Inselman, Guillermo E Umpierrez, Bobak Moazzami, Jair Munoz Mendoza, Mohammed K Ali, Katherine R Tuttle, and Rozalina G McCoy

Link

960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM), Rodolfo J. Galindo, Bobak Mozzami, Amany Y.G. Gerges, Limin Peng, Katherine R. Tuttle, and Guillermo Umpierrez

Link

961-P: Comparison of Glucose Metrics by Capillary Blood Glucose and Continuous Glucose Monitoring among People with Type 2 Diabetes on Hemodialysis, Rodolfo J. Galindo, Bobak Mozzami, Amany Y.G. Gerges, Limin Peng, Katherine R. Tuttle, and Guillermo Umpierrez

Link

960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM), Rodolfo J. Galindo, Katherine Tuttle, and See full list of authors in comments

Link

Biliary and pancreatic stents., Samuel Han; Jorge V Obando; Amit Bhatt; Juan Carlos Bucobo; Dennis Chen; Andrew P Copland; Koushik K Das; Mohit Girotra; Allon Kahn; Kumar Krishnan; Sonali S Sakaria; Monica Saumoy; Guru Trikudanathan; Arvind J Trindade; Julie Yang; Ryan J Law; ASGE Technology Committee Chair; David R Lichtenstein; and (previous Committee Chair, 2019-2021)

Link

People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action., Hiddo Jl Heerspink, David Zi Cherney, Per-Henrik Groop, Chantal Matthieu, Peter Rossing, Katherine R Tuttle, and Janet B McGill

Link

Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis., Hiddo J L Heerspink, Naveed Sattar, Imre Pavo, Axel Haupt, Kevin L Duffin, Zhengyu Yang, Russell J Wiese, Jonathan M Wilson, Andrea Hemmingway, David Z I Cherney, and Katherine Tuttle

Link

Tirzepatide reduces albuminuria in patients with type 2 diabetes: post-hoc pooled analysis of SURPASS 1-5, Hiddo J. Heerspink, Katherine Tuttle, and See full list of authors in comments

PDF

Factors impacting adherence to antidiabetic medications and health outcomes in diabetes mellitus patients in Medicare populations, Kelli Hoang, Kelly Simpson, and Danny Wallenslager

Link

The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis., Mehmet Kanbay, Sidar Copur, Dimitrie Siriopol, Abdullah B Yildiz, Metehan Berkkan, Kathherine R Tuttle, and Carmine Zoccali

Link

Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention., Judit Karacsonyi, Karen Deffenbacher, Keith H Benzuly, James D Flaherty, Khaldoon Alaswad, Mir Basir, Michael S Megaly, Farouc Jaffer, Darshan Doshi, Paul Poommipanit, Jaikirshan Khatri, Mitul Patel, Robert Riley, Abdul Sheikh, Jason R Wollmuth, Ethan C Korngold, Barry F Uretsky, Robert W Yeh, Raj H Chandwaney, Ahmed M Elguindy, Khalid Tammam, Nidal AbiRafeh, Christian W Schmidt, Brynn Okeson, Spyridon Kostantinis, Bahadir Simsek, Bavana V Rangan, Emmanouil S Brilakis, and Daniel R Schimmel

Link

Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease., Jill R Krissberg, Michelle M O'Shaughnessy, Abigail R Smith, Margaret E Helmuth, Salem Almaani, Diego H Aviles, Kaye E Brathwaite, Yi Cai, Daniel Cattran, Rasheed Gbadegesin, Dorey A Glenn, Larry A Greenbaum, Sandra Iragorri, Koyal Jain, Myda Khalid, Jason Kidd, Jeffrey Kopp, Richard Lafayette, Jerome C Lane, Francesca Lugani, Jordan G Nestor, Rulan S Parekh, Kimberly Reidy, David T Selewski, Christine B Sethna, C John Sperati, Katherine Tuttle, Katherine Twombley, Tetyana L Vasylyeva, Donald J Weaver, Scott E Wenderfer, Keisha Gibson, and CureGN Consortium

Link

Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis., Laura H Mariani, Sean Eddy, Fadhl M AlAkwaa, Phillip J McCown, Jennifer L Harder, Viji Nair, Felix Eichinger, Sebastian Martini, Adebowale D Ademola, Vincent Boima, Heather N Reich, Jamal El Saghir, Bradley Godfrey, Wenjun Ju, Emily C Tanner, Virginia Vega-Warner, Noel L Wys, Sharon G Adler, Gerald B Appel, Ambarish Athavale, Meredith A Atkinson, Serena M Bagnasco, Laura Barisoni, Elizabeth Brown, Daniel C Cattran, Gaia M Coppock, Katherine M Dell, Vimal K Derebail, Fernando C Fervenza, Alessia Fornoni, Crystal A Gadegbeku, Keisha L Gibson, Laurence A Greenbaum, Sangeeta R Hingorani, Michelle A Hladunewich, Jeffrey B Hodgin, Marie C Hogan, Lawrence B Holzman, J Ashley Jefferson, Frederick J Kaskel, Jeffrey B Kopp, Richard A Lafayette, Kevin V Lemley, John C Lieske, Jen-Jar Lin, Rajarasee Menon, Kevin E Meyers, Patrick H Nachman, Cynthia C Nast, Michelle M O'Shaughnessy, Edgar A Otto, Kimberly J Reidy, Kamalanathan K Sambandam, John R Sedor, Christine B Sethna, Pamela Singer, Tarak Srivastava, Cheryl L Tran, Katherine Tuttle, Suzanne M Vento, Chia-Shi Wang, Akinlolu O Ojo, Dwomoa Adu, Debbie S Gipson, Howard Trachtman, and Matthias Kretzler

Comparison of in-clinic only to in-clinic plus virtual mental health screens of adults with cystic fibrosis during SARS-CoV-2 pandemic, KG Mertz, M Ingoldby, T Vance, and AA Lambert

Link

Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine Tuttle

Link

Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine R Tuttle

Improvement: Increasing staff and patient awareness of and knowledge of genetic therapy research, JE Milton, A Chavez, K Kuykendall, and AA Lambert

Link

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update., Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana C N Chan, Hiddo J L Heerspink, Clint Hurst, Adrian Liew, Erin D Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing, Ian H de Boer, and Kamlesh Khunti

Link

Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney Disease., Joshua J Neumiller, Radica Alicic, and Katherine Tuttle

Link

Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States., Susanne B Nicholas, Radica Z Alicic, and Jenny Shen

Link

Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020., Susanne B Nicholas, Kenn Daratha, Radica Alicic, Cami R Jones, Lindsey M Kornowske, Joshua J Neumiller, Samuel T Fatoba, Sheldon X Kong, Rakesh Singh, Keith C Norris, and Katherine Tuttle

Link

Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial., Erika A Petersen, Thomas G Stauss, James A Scowcroft, Michael J Jaasma, Elizabeth S Brooks, Deborah R Edgar, Judith L White, Shawn M Sills, Kasra Amirdelfan, Maged N Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G Patterson, Kostandinos C Tsoulfas, Michael J Creamer, Vincent Galan, Richard H Bundschu, Neel D Mehta, Dawood Sayed, Shivanand P Lad, David J DiBenedetto, Khalid A Sethi, Johnathan H Goree, Matthew T Bennett, Nathan J Harrison, Atef F Israel, Paul Chang, Paul W Wu, Charles E Argoff, Christian E Nasr, Rod S Taylor, David L Caraway, and Nagy A Mekhail

Link

Noninvasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cutoff values., Pankaj Rajvanshi and Srikrishna Gurumurthy

Link

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley

Link

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley

Link

1460-P: Prevalence of Chronic Kidney Disease Associated with Type 1 Diabetes in the U.S., Peter Rossing, Per-Henrik Groop, Rakesh Singh, Robert Lawatscheck, and Katherine Tuttle

Phase II doseselection, randomized double-blind trial of the ASI, BI 690517, alone and in combination with EMPA in people with CKD, P Rossing, Katherine Tuttle, and Full List of Authors in Comments

Prevalence of chronic kidney disease associated with type 1 diabetes in the US, P Rossing, Katherine Tuttle, and See full list of authors in comments

Link

Evaluation of an Integrated Intervention to Address Clinical Care and Social Needs Among Patients with Type 2 Diabetes., Sarah E Roth, Benjamin Gronowski, Kyle Jones, Rachel A Smith, Sonya Kauffman Smith, Keri B Vartanian, and Bill J. Wright

Link

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial., William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman, Robin S Goland, Peter A Gottlieb, Carla J Greenbaum, Michael J Haller, Jeffrey P Krischer, Ingrid M Libman, Peter S Linsley, S Alice Long, Sandra M Lord, Daniel J Moore, Wayne V Moore, Antoinette M Moran, Andrew B Muir, Philip Raskin, Jay S Skyler, John M Wentworth, Diane K Wherrett, Darrell M Wilson, Anette-Gabriele Ziegler, and Kevan C Herold

Link

Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis., Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, Christoph Wanner, Gerasimos Filippatos, John Boletis, Katherine R Tuttle, Luis M Ruilope, Peter Rossing, Robert Toto, Stefan D Anker, Zhi-Hong Liu, Amer Joseph, Christiane Ahlers, Meike Brinker, Robert Lawatscheck, George Bakris, and FIDELIO-DKD and FIGARO-DKD Investigators

PDF

Clinical Practice Panel: Diabetes Mellitus Management in a Medical-Surgical Unit, Jane Tajonera

PDF

Analysis of eGFR vs CrCl to monitor for renal dose adjustments within Central Refill, Briana Thompson and Angela Koerner

CKD in Diabetes and the Journey to Kidney Health, Katherine Tuttle

Link

Destination Kidney Health for Diabetes and CKD, Katherine Tuttle

Link

Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors., Katherine Tuttle

Kidney Health in View for Diabetes and CKD, Katherine Tuttle

Link

Multidisciplinary Strategies for Implementation, Katherine Tuttle

"Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes", Katherine Tuttle

Link

Kidney-Heart Connection: Implications of Chronic Kidney Disease for Screening and Prevention of Heart Failure., Katherine Tuttle and Carolyn S P Lam

Link

The authors reply., Katherine R Tuttle, Heidrun Bosch-Traberg, David Z I Cherney, Samy Hadjadj, Ofri Mosenzon, Søren Rasmussen, and Stephen C Bain

Comparative effectiveness of GLP-1 receptor agonists vs DPP-4 inhibitors in patients with type 2 diabetes and moderate/severe chronic kidney disease, Katherine Tuttle and See all authors in comments

Link

Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide., Katherine Tuttle, Jonathan Matthew Wilson, Yanzhu Lin, Hui-Rong Qian, Federica Genovese, Morten Asser Karsdal, Kevin L Duffin, and Fady T Botros

Link

Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide., Katherine Tuttle, Jonathan Matthew Wilson, Yanzhu Lin, Hui-Rong Qian, Federica Genovese, Morten Asser Karsdal, Kevin L Duffin, and Fady T Botros

Link

Advances in Chronic Kidney Disease Care in Type 2 Diabetes, Carol Wysham and Katherine Tuttle

Link

Is There an Age Threshold for Active Surveillance in Highly Suspicious Subcentimeter Thyroid Nodules?, Stephanie Young and Melanie Goldfarb

Submissions from 2022

PDF

The impact of a Medicare Public Health Emergency policy change for continuous glucose monitors on utilization and total cost of care for diabetes, Momoka Abe, Katie Norton, and Jenifer Smith

Link

Benefits and risks of apps for patients., David T Ahn

Link

Unusual Case of Non-HIV Patient With Multifocal Pyomyositis: Developed on Appropriate Antibiotic Therapy., Elisa Akagi and Ashish Bhargava

Link

Use of Glucose-Lowering Agents in Diabetes and CKD., Radica Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine Tuttle

Link

Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century., Radica Alicic and Susanne B Nicholas

Link

Use of Glucose-Lowering Agents in Diabetes and CKD., Radica Z Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine R Tuttle

Link

Gut microbiota analyses of Saudi populations for type 2 diabetes-related phenotypes reveals significant association., Fahad A Al-Muhanna, Alexa K Dowdell, Abdulmohsen H Al Eleq, Waleed I Albaker, Andrew W Brooks, Ali I Al-Sultan, Abdullah M Al-Rubaish, Khaled R Alkharsah, Raed M Sulaiman, Abdulaziz A Al-Quorain, Cyril Cyrus, Rudaynah A Alali, Chittibabu Vatte, Fred L Robinson, Xin Zhou, Michael P Snyder, Afnan F Almuhanna, Brendan J Keating, Brian D. Piening, and Amein K Al-Ali

Link

Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?, John Armato, Ralph A DeFronzo, Shih-Ting Chiu, Deanna Rider, and Ronald Ruby

Link

CKD Series Episode 1: Identifying Patients at Risk for DKD Onset or Progression, George Bakris, Rajiv Agarwal, and Katherine Tuttle

Link

CKD Series Episode 2: Counseling Patients about CKD, George Bakris, Rajiv Agarwal, and Katherine Tuttle

Link

CKD Series Episode 3: Updated Approach to Managing CKD in Patients with T2DM, George Bakris, Rajiv Agarwal, and Katherine Tuttle

Link

CKD Series Episode 4: Implications of Non-steroidal MRAs for DKD, George Bakris, Rajiv Agarwal, and Katherine Tuttle

Link

CKD Series Episode 5: New and Emerging Therapies and Approaches for CKD, George Bakris, Rajiv Agarwal, and Katherine Tuttle

Link

Post-acute COVID-19 syndrome and kidney diseases: what do we know?, Sidar Copur, Metehan Berkkan, Carlo Basile, Katherine Tuttle, and Mehmet Kanbay

Link

Future of kidney imaging: Functional magnetic resonance imaging and kidney disease progression., Sidar Copur, Furkan Yavuz, Alan A Sag, Katherine Tuttle, and Mehmet Kanbay

Future of kidney imaging: Functional magnetic resonance imaging and kidney disease progression, Sidar Copur, Furkan Yavuz, Alan A. Sag, Katherine Tuttle, and Mehmet Kanbay

Link

Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?, Sidar Copur, Abdullah Yildiz, Carlo Basile, Katherine Tuttle, and Mehmet Kanbay

Link

Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)., Ian H de Boer, Kamlesh Khunti, Tami Sadusky, Katherine Tuttle, Joshua J Neumiller, Connie M Rhee, Sylvia E Rosas, Peter Rossing, and George Bakris

Link

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)., Ian H de Boer, Kamlesh Khunti, Tami Sadusky, Katherine Tuttle, Joshua J Neumiller, Connie M Rhee, Sylvia E Rosas, Peter Rossing, and George Bakris

PDF

Immune Checkpoint Inhibitor Induced Type 1 Diabetes Mellitus: A Pembrolizumab Case Study, Michael R. Dirks Jr.

Link

A Century of Diabetes Success: The Past as Prologue, Boris Draznin, Mikhail Kosiborod, Katherine Tuttle, and Clifford Goodman (moderator)

Link

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)

Link

Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part II: Physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations., Barry A Franklin, Thijs M H Eijsvogels, Ambarish Pandey, John Quindry, and Peter P Toth

Link

Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society., Allon N Friedman, Philip R Schauer, Srinivasan Beddhu, Holly Kramer, Carel W le Roux, Jonathan Q Purnell, Duane Sunwold, Katherine R Tuttle, Ania M Jastreboff, and Lee M Kaplan

Link

Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society., Allon N Friedman, Philip R Schauer, Srinivasan Beddhu, Holly Kramer, Carel W le Roux, Jonathan Q Purnell, Duane Sunwold, Katherine R Tuttle, Ania M Jastreboff, and Lee M Kaplan

Link

Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD, Rodolfo J. Galindo, Ian H. de Boer, Joshua J. Neumiller, and Katherine Tuttle

Link

Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes., Rodolfo J Galindo, Francisco J Pasquel, Priyathama Vellanki, Radica Alicic, David W Lam, Maya Fayfman, Alexandra L Migdal, Georgia M Davis, Saumeth Cardona, Maria A Urrutia, Citlalli Perez-Guzman, Karla Walkiria Zamudio-Coronado, Limin Peng, Katherine Tuttle, and Guillermo E Umpierrez

Link

Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney Disease., Jasleen K Ghuman and Katherine Tuttle

Link

A perspective on nonsteroidal mineralocorticoid receptor antagonism in diabetic kidney disease, Jasleen K. Ghuman and Katherine Tuttle

Link

Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis., Debbie S Gipson, Jonathan P Troost, Cathie Spino, Samara Attalla, Joshua Tarnoff, Susan Massengill, Richard Lafayette, Virginia Vega-Warner, Sharon Adler, Patrick Gipson, Matthew Elliott, Frederick Kaskel, Damian Fermin, Marva Moxey-Mims, Richard N Fine, Elizabeth J Brown, Kimberly Reidy, Katherine Tuttle, Keisha Gibson, Kevin V Lemley, Larry A Greenbaum, Meredith A Atkinson, Sangeeta Hingorani, Tarak Srivastava, Christine B Sethna, Kevin Meyers, Cheryl Tran, Katherine M Dell, Chia-Shi Wang, Jennifer Lai Yee, Matthew G Sampson, Rasheed Gbadegesin, J J Lin, Tammy Brady, Michelle Rheault, and Howard Trachtman

Link

Differences in the management of thyroid nodules in children and adolescents as compared to adults., Melanie Goldfarb and Catherine Dinauer

Link

Survivorship, Quality of Life, and Transition to Adult Care for Pediatric and Adolescent Thyroid Cancer Survivors., Melanie Goldfarb and Aime T Franco

PDF

TRUST BUT VERIFY: ETHICAL CONSIDERATIONS OF POTENTIAL MISDIAGNOSES AND INCORRECT PATIENT DIAGNOSES, Eric Grisham

Link

Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial., Hiddo J L Heerspink, Naveed Sattar, Imre Pavo, Axel Haupt, Kevin L Duffin, Zhengyu Yang, Russell J Wiese, Katherine Tuttle, and David Z I Cherney

Link

Radiofrequency ablation in the management of primary hepatic and biliary tumors., Richard Hendriquez, Tara Keihanian, Jatinder Goyal, Rtika R Abraham, Rajnish Mishra, and Mohit Girotra